A detailed history of Verition Fund Management LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Verition Fund Management LLC holds 212,151 shares of BCYC stock, worth $3.11 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
212,151
Previous 266,749 20.47%
Holding current value
$3.11 Million
Previous $5.4 Million 10.87%
% of portfolio
0.03%
Previous 0.03%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$19.58 - $27.24 $1.07 Million - $1.49 Million
-54,598 Reduced 20.47%
212,151 $4.81 Million
Q2 2024

Aug 14, 2024

SELL
$20.02 - $24.69 $1.48 Million - $1.83 Million
-74,117 Reduced 21.74%
266,749 $5.4 Million
Q1 2024

May 14, 2024

SELL
$16.75 - $26.1 $6.69 Million - $10.4 Million
-399,673 Reduced 53.97%
340,866 $8.49 Million
Q4 2023

Feb 14, 2024

SELL
$13.29 - $22.2 $2.34 Million - $3.9 Million
-175,843 Reduced 19.19%
740,539 $13.4 Million
Q3 2023

Nov 14, 2023

BUY
$19.9 - $26.25 $4.72 Million - $6.23 Million
237,370 Added 34.96%
916,382 $18.4 Million
Q2 2023

Aug 14, 2023

BUY
$18.95 - $28.67 $1.83 Million - $2.77 Million
96,454 Added 16.56%
679,012 $17.3 Million
Q1 2023

May 15, 2023

BUY
$20.02 - $31.37 $4.04 Million - $6.33 Million
201,709 Added 52.96%
582,558 $12.4 Million
Q4 2022

Feb 14, 2023

BUY
$20.37 - $32.9 $658,684 - $1.06 Million
32,336 Added 9.28%
380,849 $11.3 Million
Q3 2022

Nov 14, 2022

SELL
$17.49 - $28.44 $883,419 - $1.44 Million
-50,510 Reduced 12.66%
348,513 $8.11 Million
Q2 2022

Aug 15, 2022

BUY
$12.95 - $46.99 $3.43 Million - $12.4 Million
264,819 Added 197.33%
399,023 $6.7 Million
Q1 2022

May 13, 2022

SELL
$40.12 - $59.5 $1.22 Million - $1.82 Million
-30,511 Reduced 18.52%
134,204 $5.89 Million
Q4 2021

Feb 14, 2022

SELL
$41.7 - $61.14 $606,568 - $889,342
-14,546 Reduced 8.11%
164,715 $10 Million
Q3 2021

Nov 15, 2021

SELL
$27.95 - $44.24 $911,533 - $1.44 Million
-32,613 Reduced 15.39%
179,261 $7.46 Million
Q2 2021

Aug 16, 2021

SELL
$27.0 - $32.28 $763,020 - $912,232
-28,260 Reduced 11.77%
211,874 $6.43 Million
Q1 2021

May 18, 2021

BUY
$19.12 - $30.25 $3.94 Million - $6.24 Million
206,300 Added 609.74%
240,134 $7.17 Million
Q4 2020

Feb 16, 2021

BUY
$17.95 - $21.36 $50,313 - $59,872
2,803 Added 9.03%
33,834 $607,000
Q3 2020

Nov 16, 2020

BUY
$15.3 - $20.8 $474,774 - $645,444
31,031 New
31,031 $591,000

Others Institutions Holding BCYC

About BICYCLE THERAPEUTICS plc


  • Ticker BCYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,676,100
  • Market Cap $436M
  • Description
  • Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...
More about BCYC
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.